Detailed Information
Cited 0 time in 
Cited 0 time in 
Cited 0 time in
Metadata Downloads
A phase III, randomized study of atezolizumab plus bevacizumab and chemotherapy in patients with EGFR or ALK mutated in non-small cell lung cancer (ATTLAS, KCSG-LU19-04)open access
- Authors
- Ahn, M. J.; Park, S.; Kim, T. M.; Han, J. Y.; Lee, G. W.; Shim, B.; Lee, Y. G.; Kim, S. W.; Kim, I. H.; Lee, S.; Kim, Y. J.; Park, J. H.; Park, S. G.; Lee, K. H.; Kang, E. J.; Kim, J. W.; Shin, S. H.
- Issue Date
- Oct-2023
- Publisher
- ELSEVIER
- Citation
- ANNALS OF ONCOLOGY, v.34, pp S1311 - S1311
- Indexed
- SCIE
SCOPUS
- Journal Title
- ANNALS OF ONCOLOGY
- Volume
- 34
- Start Page
- S1311
- End Page
- S1311
- ISSN
- 0923-7534
1569-8041
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - College of Medicine > Department of Medical Science > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
Related Researcher
- Kang, Eun Joo
- College of Medicine (Department of Medical Science)